Max Healthcare Institute enterprise value

Share price at each year-end

Tap a line for its trend	Currentlast 12M	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus


79,310	—	—	—	—	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
557	666	662	980	42.8
201	0.0	0.0	0.0	0.0
3,478	3,478	3,010	1,299	689
82,433	—	—	—	—
2,922	2,813	2,349	319	646
₹847.09	—	—	—	—

15,011	14,225	12,391	9,707	8,099
23.2%	24.5%	24.3%	13.4%	8.5%
0.04×	—	—	—	—

9.01×	—	—	—	—
33.58×	—	—	—	—
42.25×	—	—	—	—
554.02×	—	—	—	—
9,146	8,373	7,028	5,406	4,563
2,455	2,243	1,849	1,492	1,241
1,951	1,796	1,489	1,247	1,008
—	1,633	1,460	1,122	1,209
149	149	494	343	874
—	117	461	301	874
—	1,485	966	779	336

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

MAXHEALTH₹815.00

Max Healthcare Institute Ltd.

· Pharma & Health

₹ CrorePeersAPOLLOHOSP FORTIS MEDANTA DRREDDY CIPLA SUNPHARMA DIVISLAB TORNTPHARMMcap ₹79,310 Cr

HighlightsEnterprise Value Multiples Per ShareAnnuals · FY-end closes

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Current/LTM TTM · last close
Market Capitalization	—	—	—	—	79,310.1
- Cash, Equiv & ST Investments	42.8	979.8	661.6	665.8	556.7
+ Minority Interest	0.0	0.0	0.0	0.0	201.1
+ Total Debt	689.0	1,299.0	3,010.3	3,478.4	3,478.4
Enterprise Value	—	—	—	—	82,432.8
Net Debt (memo)	646.2	319.1	2,348.7	2,812.6	2,921.7
EV per Share	—	—	—	—	847.09

Total Capital	8,098.6	9,707.1	12,391.2	14,225.0	15,011.5
Total Debt/Total Capital	8.51	13.38	24.29	24.45	23.17
Total Debt/EV	—	—	—	—	0.04

EV/Sales	—	—	—	—	9.01
EV/EBITDA	—	—	—	—	33.58
EV/EBIT	—	—	—	—	42.25
EV/Free Cash Flow	—	—	—	—	554.02
Reference Items — Trailing FY Values
Sales	4,562.6	5,406.0	7,028.5	8,373.5	9,145.8
EBITDA	1,240.5	1,492.1	1,848.8	2,242.8	2,454.7
EBIT	1,008.3	1,247.1	1,489.4	1,796.3	1,951.1
Operating Cash Flow	1,209.2	1,121.8	1,459.7	1,633.3	—
Free Cash Flow	873.6	343.0	494.1	148.8	148.8
FCFF (free cash flow to the firm)	873.6	300.8	461.1	117.2	—
Capital Expenditure	335.6	778.8	965.5	1,484.5	—

Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 146%.